Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Levie SE"'
Publikováno v:
Blood; September 1993, Vol. 82 Issue: 6 p1937-1938, 2p
Autor:
de Jong G; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands., Bartels L; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands., Kedde M; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Verdegaal EME; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Gillissen MA; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Cercel MG; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., van Hal-van Veen SE; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Fatmawati C; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., van de Berg D; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Claassen YB; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Bakker AQ; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Schotte R; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Villaudy J; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Amsterdam, The Netherlands.; Amsterdam Infection and Immunity Institute (AI&II), Amsterdam, The Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands. pmvanhelden@aimmtherapeutics.com., Wagner K; AIMM Therapeutics, Meibergdreef 59, 1105 BA, Amsterdam, The Netherlands.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Jun; Vol. 70 (6), pp. 1569-1581. Date of Electronic Publication: 2020 Nov 23.
Autor:
Gillissen MA; AIMM Therapeutics and.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kedde M; AIMM Therapeutics and., Jong G; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Moiset G; AIMM Therapeutics and.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics and., Levie SE; AIMM Therapeutics and., Bakker AQ; AIMM Therapeutics and., Claassen YB; AIMM Therapeutics and., Wagner K; AIMM Therapeutics and., Böhne M; AIMM Therapeutics and., Hensbergen PJ; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; and., Speijer D; Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics and., Beaumont T; AIMM Therapeutics and., Spits H; AIMM Therapeutics and., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2018 Jan 04; Vol. 131 (1), pp. 131-143. Date of Electronic Publication: 2017 Oct 23.
Autor:
Gillissen MA; AIMM Therapeutics, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., de Jong G; AIMM Therapeutics, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kedde M; AIMM Therapeutics, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Amsterdam, The Netherlands., Moiset G; AIMM Therapeutics, Amsterdam, The Netherlands., Hensbergen PJ; Center for Proteomics and Metabolomics, University Medical Center, Leiden, The Netherlands; and., Bakker AQ; AIMM Therapeutics, Amsterdam, The Netherlands., Wagner K; AIMM Therapeutics, Amsterdam, The Netherlands., Villaudy J; AIMM Therapeutics, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.; Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2017 Aug 18; Vol. 1 (19), pp. 1551-1564. Date of Electronic Publication: 2017 Aug 18 (Print Publication: 2017).
Autor:
Gillissen MA; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., de Jong G; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands.; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Bakker AQ; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Evers LM; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Pals ST; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands., Huisman C; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2016 Sep; Vol. 51 (9), pp. 1245-8. Date of Electronic Publication: 2016 Apr 18.
Autor:
Gillissen MA; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Yasuda E; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., de Jong G; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Levie SE; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Go D; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Spits H; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., van Helden PM; AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands., Hazenberg MD; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: m.d.hazenberg@amc.nl.
Publikováno v:
Journal of immunological methods [J Immunol Methods] 2016 Jul; Vol. 434, pp. 16-23. Date of Electronic Publication: 2016 Apr 13.